An important point about the updated guidelines is the emphasis on individualized treatment of complicated UTIs, recognizing ...

The company reported a second-quarter earnings beat and raised full-year sales guidance, boosted by a strong performance at ...

The pharmaceutical company said it remained confident in the benefit and risk profile of Blenrep and will continue to work ...

More than half of severe COVID-19 survivors show fibrotic-like lung abnormalities even 3 years after infection, especially ...

AstraZeneca PLC (NASDAQ:AZN) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. AstraZeneca PLC (NASDAQ:AZN ...

The decline in the company's share price came as its shares traded ex-date following the announcement of a ₹32 per share ...

AstraZeneca (AZN) announced Enhertu in combination with pertuzumab has been granted Breakthrough Therapy Designation in the U ...

AstraZeneca has briefed councillors on their plans to build a new office and conference centre at the Cambridge Biomedical ...

Britain's stock market finally appears to be reversing years of underperformance against the rest of Europe, as a UK/US trade ...

The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 ...

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

Digital health startups in the city saw an uptick in funding in the first half of the year as late-stage life science and ...